Search results
Aug 18, 2022 · The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 in people aged 18 years and older.
Feb 3, 2021 · The Moderna COVID-19 vaccine has been authorised for use in Singapore in individuals aged 18 years and above. The first shipment arrived in Singapore on 17 February 2021. Details of the Moderna COVID-19 vaccine. For individuals aged 18 years and above; Two doses required, administered 28 days apart; High vaccine efficacy of 94%
2. What is the Moderna/Spikevax COVID-19 vaccine? The Moderna/Spikevax COVID-19 vaccine protects against COVID-19. The vaccine contains messenger RNA (mRNA) which helps your immune system to produce protection. The vaccine reduces the risks of infection and severe disease from COVID-19, and has good protection against the current virus variants.
v. t. e. The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
Pfizer-BioNTech, Moderna and Novavax have successfully obtained full registration for their vaccines. Sinovac-CoronaVac vaccine continues to be included under the National Vaccination Programme (NVP)* until 30 September 2024.
Apr 30, 2024 · The Moderna vaccine is an mRNA vaccine, similar to the one developed by Pfizer. The technology behind these vaccines has been around for about three decades and shown promise in preventing notoriously difficult-to-prevent diseases—even cancer.
2. What is the Moderna COVID-19 vaccine? The Moderna COVID-19 vaccine protects against COVID-19. The vaccine contains messenger RNA (mRNA) which helps your immune system to produce protection. The vaccine reduces the risks of infection and severe disease from COVID-19, and has good protection against the current virus variants.
